Global /South Korea /Healthcare /Drug Manufacturers - General /464280

Tdspharm Co., Ltd.

464280

• KRX: 464280 • Delayed

9,260KRW -0.2%

6.10 USD

As of 14 June 2026, Tdspharm Co., Ltd. has a market cap of $33.74M USD, ranking #33426 globally and #2025 in South Korea. It ranks #3018 in the Healthcare sector, and #1035 in the Drug Manufacturers - General industry.

Global Rank

33426

Country Rank

2025

Sector Rank

3018

Industry Rank

1035

Key Stats

Market Cap

$33.74MUSD

51.32B KRW

Enterprise Value

$25.57MUSD

38.82B KRW

Revenue (TTM)

$18.16MUSD

27.62B KRW

EBITDA (TTM)

$2.94MUSD

4.46B KRW

Net Income (TTM)

$2.81MUSD

4.27B KRW

EBITDA Margin

16%

Profit Margin

15%

PE Ratio

11.5

PS Ratio

1.9

PB Ratio

1.2

EV/EBITDA

8.7

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Founded

2002

Website

tdspharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	8.2%	3.7%	-6.9%	-0.6%	-5.8%	-27%	-76%	-76%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	464280 TDS Pharm Co Ltd ISIN: KR7464280007 Shares Out.: Shares Outstanding: 5.289M¹ Shares Float: 2.823M² TV: TradingView: KRX: 464280 SA: Stock Analysis: KRX: 464280 YF: Yahoo Finance: 464280.KS GF: Google Finance: KRX: 464280 BA: Barron's: 464280 MS: Morningstar: XKRX: 464280	9,260 KRW	TV: TradingView: KRX: 464280 SA: Stock Analysis: KRX: 464280 YF: Yahoo Finance: 464280.KS GF: Google Finance: KRX: 464280 BA: Barron's: 464280 MS: Morningstar: XKRX: 464280

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tdspharm Co., Ltd.

Tdspharm Co., Ltd. researches, develops, and produces pharmaceuticals and cosmetics in South Korea and internationally. It offers general medicines, prescription drugs, and non-medicinal products. The company was founded in 2002 and is based in Seongnam-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 27K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 20K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 15K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 15K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 13K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 13K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 953K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 856K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 814K%	20.5	Switzerland

chevron_leftBack